{
    "clinical_study": {
        "@rank": "164687", 
        "acronym": "IVBICONCOL", 
        "arm_group": [
            {
                "arm_group_label": "IV bicarbonate 4.2% 20 cc", 
                "arm_group_type": "Experimental", 
                "description": "injecting 20cc 4.2% to a newly administered IV line"
            }, 
            {
                "arm_group_label": "IV normal saline", 
                "arm_group_type": "Placebo Comparator", 
                "description": "injecting 20 cc normal saline to a newly administered IV line"
            }
        ], 
        "brief_summary": {
            "textblock": "The investigators use bicarbonate injected to an intravenous line and the changes in the\n      exhaled end-tidal carbon dioxide to verify whether the IV line is in the vein or surrounding\n      tissue"
        }, 
        "brief_title": "Intravenous Bicarbonate To Verify The Correct Position of IV Catheters in Oncological Patients Oncological Patients Receiving Chemotherapy", 
        "completion_date": {
            "#text": "December 2013", 
            "@type": "Anticipated"
        }, 
        "condition": "Detection of the Correct Position of Intravenous Line", 
        "detailed_description": {
            "textblock": "The method was proved useful in previous phase I, II studies. Now the investigators move on\n      to assess the method in a phase III study in oncological patients.\n\n      each patients which will be subjected to intravenous chemotherapy will be eligible ( see\n      also inclusion/exclusion criteria).\n\n      Once consent obtained the patient will have an IV line placed. each line placed will be\n      categorized by the clinical team into 3 categories:\n\n        1. IV in place ready to use for chemotherapy ( good blood return)\n\n        2. Doubtful position ( no blood return/ little blood return bu flushes well).\n\n        3. IV not in place. Study design Category 1. IV bicarbonate 4.2% 20 cc and NS 20 cc in a\n           randomized fashion Category 2. same as above Category 3. No injections"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  age 18-80 oncological disease requires intravenous chemotherapy\n\n        Exclusion Criteria:\n\n          -  1. refusal to participate 2. lung disease acute or chronic sPo2 < 92%, PaCO2 > 50 3.\n             renal failure Creatinine > 2 mg% 4. metabolic alkalosis HCO3 > 30 meq/L 5. medication\n             that affect bicarbonate levels: Bicarbonate, Diamox, Fusid 6. obesity BMI > 38 7.\n             congestive heart failure EF < 40 % or clinical signs of congestive heart failure"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "80 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "100", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 10, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01748097", 
            "org_study_id": "IV BIC for IVONCOL"
        }, 
        "intervention": {
            "arm_group_label": "IV bicarbonate 4.2% 20 cc", 
            "intervention_name": "sodium bicarbonate 4.2%", 
            "intervention_type": "Drug"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "infiltration", 
            "extravasation", 
            "sodium bicarbonate", 
            "capnography", 
            "end tidal carbon dioxide", 
            "chemotherapy"
        ], 
        "lastchanged_date": "December 30, 2012", 
        "location": [
            {
                "contact": {
                    "email": "ilan.keidan@sheba.health.gov.il", 
                    "last_name": "ilan keidan, MD", 
                    "phone": "972526669370"
                }, 
                "facility": {
                    "address": {
                        "city": "Tel Hashomer", 
                        "country": "Israel", 
                        "zip": "52621"
                    }, 
                    "name": "Oncology Clinic"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "ilan.keidan@sheba.health.gov.il", 
                    "last_name": "ilan keidan, MD", 
                    "phone": "07235302754"
                }, 
                "facility": {
                    "address": {
                        "city": "Tel Hashomer", 
                        "country": "Israel", 
                        "zip": "52621"
                    }, 
                    "name": "Sheba Medical Center Oncology"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "Israel"
        }, 
        "number_of_arms": "2", 
        "official_title": "Phase III Study to Assess the Utility of a New Innovative Technique Using Intravenous Bicarbonate to Verify the Correct Position of Patients Scheduled for Intravenous Bicarbonate", 
        "overall_contact": {
            "email": "ilan.keidan@sheba.health.gov.il", 
            "last_name": "ilan keidan, MD", 
            "phone": "97235302754"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Israel: Ministry of Health", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 2/Phase 3", 
        "primary_completion_date": {
            "#text": "December 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "the injection of bicarbonate in a vein cause a rapid and distinct change in exhaled end-tidal CO2", 
            "measure": "change in exhaled end tidal co2", 
            "safety_issue": "Yes", 
            "time_frame": "1-3 minutes"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01748097"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Sheba Medical Center", 
            "investigator_full_name": "Dr. Ilan Keidan", 
            "investigator_title": "director pediatric anesthesia", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Sheba Medical Center", 
        "sponsors": {
            "collaborator": {
                "agency": "Netherlands: Ministry of Health, Welfare and Sports", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Sheba Medical Center", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "December 2012", 
        "study_design": "Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Diagnostic", 
        "study_type": "Interventional", 
        "verification_date": "December 2012"
    }
}